Skip to main content
OpenTrials
Completed

NCT Number: NCT03292978

An Intervention on Healthy Adults of Probiotics on Gut Flora Metabolisms of Choline

The aim of the study is to examine the effects of probiotics intervention on choline metabolites and intestinal microbiota composition using a randomized double blind clinical trial. Also, we proposed to explore the real-time change of choline metabolites after probiotics intervention through a PC challenge test. Our study will clarify the biochemical pathway involved in metabolic diseases and hope to provide a new targeted-preventive and therapeutic strategy for chronic metabolic diseases.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

SunYat-sen University

Guangzhou, Guangdong, 510080, China

About this study

Dietary choline (mainly refer to phosphatidylcholine, PC) produce trimethylamine (TMA) through the action of gut flora in vivo. TMA then readily absorbed into systemic circulation and oxidized by hepatic flavin monoxygenases (FMO3) to trimethylamine-N-oxide (TMAO). The elevated levels of circulating TMAO is identified as a risk factor for the prevalence and development of metabolic diseases such as cardiovascular diseases and nonalcoholic fatty liver diseases. Targeting gut flora for reducing TMAO may be a promising approach for preventing chronic metabolic diseases. Recent studies found that some strains representing two different phyla (Firmicutes and Proteobacteria) are capable of producing TMA from choline in vitro. On the other hand, TMA intervention can change the structure of intestinal flora, reducing the abundance of bifidobacterium and lactobacillus. Probiotics can improve the ecological balance of the gut flora, which might be beneficial to human health and disease prevention. However, whether probiotics could inhibit the TMA-producing bacterias and reduce the TMA and TMAO levels through balancing the gut flora was unclear.

In order to explore whether probiotics can reduce the TMA and TMAO levels, we are proposed to recruit 50 volunteers aged from 18-30 years old to participate in the randomized double-blind trial. The volunteers are randomized allocated into different intervention groups. The probiotics intervention group is provided once daily orally-taken powder in a sachet, which contains 4 strains of probiotics. The non-probiotic control is provided with a powder without probiotics , but has same look, color, taste, flavor and weight as the probiotics intervention group. A PC challenge test will be hold before and after the 4 weeks intervention. The blood and fecal sample will be collected before and after the trial and analyzed by appropriate method. The dietary assessment is assessed by a 3-day dietary record.The statistic analysis is by SPSS 23.0.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy males at 18 to 30 years old;
  • Free from antibiotics and probiotic products for at least 1 month;
  • Willing to participate in the study, consume the test product and perform all measurements.

Exclusion criteria

  • Sever physical diseases;
  • Intolerance to probiotics or eggs

Treatment and study plan

probiotics intervention

Dietary Supplement

The probiotics intention is provided with 4 strains of probiotics as a 2g sachet powder, dried with corn starch for 4 weeks.

non-probiotic control

Dietary Supplement

The placebo is corn starch alone provided and the shape, color, flavor and taste are same with the powder of probiotics intervention.

Primary outcomes

  1. choline metabolites

    Time frame: 4 weeks later

    The metabolites of choline before and after the intervention including free choline, betaine, TMA, TMAO will be measured by UPLC/MS.

Secondary outcomes

  1. intestinal microbiota composition

    Time frame: 4 weeks later

    The intestinal microbiota composition of feces before and after the intervention will be examined by 16S-DNA.

  2. anthropometry measurement

    Time frame: 4 weeks later

    The height and weight which are combined to report BMI in kg/m^2 will be measured before and after the intervention by professional investigators.

  3. blood biochemical markers

    Time frame: 4 weeks later

    Overnight fasting serum total cholesterol (TC), triglyceride (TG), LDL cholesterol (LDLc), HDL cholesterol (HDLc) and fasting blood glucose were measured by colorimetric methods using a Hitachi 7600-010 automated analyzer.

Sponsors and collaborators

Lead sponsor

Huilian Zhu

Other

Registry information

Official study title

Probiotics Intervention on Gut Flora Metabolisms of Choline:A Randomized Double-Blind Control Trial

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Sep 26, 2017
Registry last updated
Nov 13, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.